Alzheimer's Disease Clinical Trials in The Villages, Florida

5 studies are recruiting for alzheimer's disease in The Villages, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

    Stage
    Phase 3
    Ages
    60 to 85
    Site
    Local Institution - 0129, The Villages, Florida
    Locations
    127 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT06976203 on ClinicalTrials.gov

  2. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    The purpose of this study is to evaluate the efficacy and safety of KarXT + KarX-EC for cognitive impairment in Alzheimer's Disease

    Stage
    Phase 3
    Ages
    60 to 85
    Site
    Charter Research - Lady Lake, The Villages, Florida
    Locations
    119 in total
    Run by
    Bristol-Myers Squibb

    See if you can join NCT06976216 on ClinicalTrials.gov

  3. A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

    This is a randomized, placebo-controlled Phase 2 study to evaluate the efficacy and safety of SAR448851 in early Alzheimer's disease (AD) participants. The purpose of this study is to measure efficacy and safety with once daily oral SAR448851 compared to placebo in participants with mild cognitive …

    Stage
    Phase 2
    Ages
    55 to 85
    Site
    Charter Research - Lady Lake- Site Number : 8400004, The Villages, Florida
    Run by
    Sanofi

    See if you can join NCT07688213 on ClinicalTrials.gov

  4. A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

    The purpose of this study is to assess the safety, tolerability, immunogenicity and pharmacodynamic effects of ACI-24.060 in subjects with prodromal Alzheimer's disease and in non-demented adults with Down syndrome.

    Stage
    Phase 1
    Ages
    35 to 85
    Site
    Charter Research, LLC, The Villages, Florida
    Locations
    26 in total
    Run by
    AC Immune SA

    See if you can join NCT05462106 on ClinicalTrials.gov

  5. A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

    This is a multicentre, randomized, double-blind, placebo-controlled, parallel group Phase II study to evaluate the efficacy and safety of VHB937 in participants with early AD followed by an Extension. The double-blind part is 72 weeks long, followed by an extension.

    Stage
    Phase 2
    Ages
    50 to 85
    Site
    Charter Research The Villages, The Villages, Florida
    Locations
    74 in total
    Run by
    Novartis Pharmaceuticals

    See if you can join NCT07094516 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.